# Trade Mark Journal No.2026/010 6 March 2026

## UK00004343277 20 February 2026 (5)

Mark 1

RE-AIM

Mark 2

RE-AIM THERAPEUTICS

Class 5
  Pharmaceuticals; therapeutics; pharmaceuticals and therapeutics for the treatment of autoimmune diseases; pharmaceuticals and therapeutics for the treatment of inflammatory diseases and conditions; pharmaceuticals and therapeutics for the treatment of irritable bowel disease, metabolic disorders, psoriasis, psoriatic arthritis, hidradenitis suppurativa and ankylosing spondylitis.

Re-Aim Therapeutics Ltd

Representative: Kilburn & Strode LLP